MoonLake Immunotherapeutics (MLTX)

Last Closing Price: 54.80 (2025-08-28)

Loss Ratio (Quarterly)

Loss Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The loss ratio is calculated by taking the incurred underwriting losses and then dividing them by earned premium. Calculated as: Underwriting Losses Total / Net Premiums Earned

MoonLake Immunotherapeutics (MLTX) Loss Ratio data is not available.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
--
$-55.22M
--
--
$60.70M
$-60.70M
$4.74M
$-55.96M
$-55.96M
$-56.05M
$-56.05M
$-56.05M
$-56.05M
$-60.70M
$-59.96M
63.28M
63.28M
$-0.87
$-0.87
Balance Sheet Financials
$455.48M
$0.67M
$4.62M
$460.10M
$27.36M
$73.38M
$74.79M
$102.15M
$357.94M
$357.94M
$357.94M
64.20M
Cash Flow Statement Financials
$-92.67M
$144.50M
$73.12M
$180.43M
$306.68M
$126.25M
$5.60M
--
--
Fundamental Metrics & Ratios
16.65
--
--
0.17
0.20
--
--
--
--
--
--
$-92.70M
Loss Ratio
--
--
--
--
--
--
--
-15.66%
-15.66%
-12.18%
-13.00%
$5.58
$-1.46
$-1.46